HTR2B and IgG4-related retroperitoneal fibrosis: In the 1980s, another link was established between retroperitoneal fibrosis and methysergide resulting from the metabolism of this compound into methylergonovine, which converts it from a 5-hydroxytryptamine 2B receptor antagonist to an agonist [79].